Literature DB >> 19684014

Genetics of Behçet disease inside and outside the MHC.

Akira Meguro1, Hidetoshi Inoko, Masao Ota, Yoshihiko Katsuyama, Akira Oka, Eiichi Okada, Ryoji Yamakawa, Takenosuke Yuasa, Toshihiko Fujioka, Shigeaki Ohno, Seiamak Bahram, Nobuhisa Mizuki.   

Abstract

BACKGROUND: Behçet disease (BD) is a rare, chronic, systemic, inflammatory disorder characterised by recurrent ocular, genital and skin lesions. Although its aetiology is still uncertain, an intricate interplay between the environment (eg, viruses) and the host seems to initiate and/or perpetuate the disease, although the mechanism remains speculative. Since the identification of HLA-B*5101 (and more recently of MICA) as a susceptibility locus for BD, the identification of additional genetic locus/loci, whether inside, or perhaps more importantly outside the MHC has clearly stalled.
OBJECTIVE: To carry out a genome-wide association study (GWAS) of BD.
METHODS: 300 Japanese patients with BD and an equal number of controls were recruited. The samples were screened using a dense panel of 23 465 microsatellites (MS) covering the entire genome.
RESULTS: The six best (of a total of 147) positively associated MS with BD were identified. Of these six, two were located within the human leucocyte antigen (HLA) class I region itself. Although one of these was clearly reminiscent of the association with HLA-B, the second, not in linkage disequilibrium with the former, was in the telomeric side of the class I region and remained to be formally identified. HLA genotyping and haplotype analysis conclusively led to the deciphering of a dual, independent, contribution of two HLA alleles to the pathogenesis of BD: HLA-B*5101 and HLA-A*26.
CONCLUSIONS: This GWAS highlights the premier genetic susceptibility locus for BD as the major histocompatibility complex itself, wherein reside two independent loci: HLA-B and HLA-A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684014     DOI: 10.1136/ard.2009.108571

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

1.  Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci.

Authors:  Nobuhisa Mizuki; Akira Meguro; Masao Ota; Shigeaki Ohno; Tomoko Shiota; Tatsukata Kawagoe; Norihiko Ito; Jiro Kera; Eiichi Okada; Keisuke Yatsu; Yeong-Wook Song; Eun-Bong Lee; Nobuyoshi Kitaichi; Kenichi Namba; Yukihiro Horie; Mitsuhiro Takeno; Sunao Sugita; Manabu Mochizuki; Seiamak Bahram; Yoshiaki Ishigatsubo; Hidetoshi Inoko
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

2.  On the genetics of the Silk Route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behçet's disease in an Iranian population.

Authors:  Raphael Carapito; Farhad Shahram; Sandra Michel; Marion Le Gentil; Mirjana Radosavljevic; Akira Meguro; Bahar Sadeghi Abdollahi; Hidetoshi Inoko; Masao Ota; Fereydoun Davatchi; Seiamak Bahram
Journal:  Immunogenetics       Date:  2015-05-05       Impact factor: 2.846

3.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

Review 4.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

5.  Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity.

Authors:  Michael J Ombrello; Yohei Kirino; Paul I W de Bakker; Ahmet Gül; Daniel L Kastner; Elaine F Remmers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 6.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

Review 7.  Role of genetics in pediatric rheumatology.

Authors:  Eda Tahir Turanlı; Elif Everest; Ayşe Balamir; Aslı Kireçtepe Aydın; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2017-09-01

8.  Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia.

Authors:  Anton Lennikov; Zemfira Alekberova; Regina Goloeva; Nobuyoshi Kitaichi; Lev Denisov; Kenichi Namba; Mitsuhiro Takeno; Yoshiaki Ishigatsubo; Nobuhisa Mizuki; Eugeny Nasonov; Susumu Ishida; Shigeaki Ohno
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

9.  [Genetic risk factors for vasculitis].

Authors:  J U Holle; W L Gross
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

10.  Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.

Authors:  Elaine F Remmers; Fulya Cosan; Yohei Kirino; Michael J Ombrello; Neslihan Abaci; Colleen Satorius; Julie M Le; Barbara Yang; Benjamin D Korman; Aris Cakiris; Oznur Aglar; Zeliha Emrence; Hulya Azakli; Duran Ustek; Ilknur Tugal-Tutkun; Gulsen Akman-Demir; Wei Chen; Christopher I Amos; Michael B Dizon; Afet Akdag Kose; Gulsevim Azizlerli; Burak Erer; Oliver J Brand; Virginia G Kaklamani; Phaedon Kaklamanis; Eldad Ben-Chetrit; Miles Stanford; Farida Fortune; Marwen Ghabra; William E R Ollier; Young-Hun Cho; Dongsik Bang; John O'Shea; Graham R Wallace; Massimo Gadina; Daniel L Kastner; Ahmet Gül
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.